Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhiqiang Qin
Association of N-Acetyltransferase 1 Polymorphism and Bladder Cancer Risk: An Updated Meta-Analysis and Trial Sequential Analysis
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Identification of Key Genes and microRNAs Involved in Kidney Wilms Tumor by Integrated Bioinformatics Analysis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
‹
1
2
Related publications
Association Between lncRNA H19 Rs217727 Polymorphism and the Risk of Cancer: An Updated Meta-Analysis
BMC Medical Genetics
Genetics
Association of Angiotensin ІІ Type 1 Receptor Gene A1166C Polymorphism With Cancer Risk: An Updated Meta-Analysis
JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal Medicine
Endocrinology
Association Between an Indel Polymorphism Within the Distal Promoter of EGLN2 and Cancer Risk: An Updated Meta‐analysis
Molecular genetics & genomic medicine
Genetics
Molecular Biology
An Association Between hOGG1Ser326Cys Polymorphism and the Risk of Bladder Cancer in Non-Smokers: A Meta-Analysis
BMC Cancer
Cancer Research
Oncology
Genetics
Cigarette Smoking, N-Acetyltransferase 2 Genotypes, and Breast Cancer Risk: Pooled Analysis and Meta-Analysis
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
No Association Between XRCC1 Gene Arg194Trp Polymorphism and Risk of Lung Cancer: Evidence Based on an Updated Cumulative Meta-Analysis
Tumor Biology
Medicine
Cancer Research
Polymorphism in IGFBP3 Gene Is Associated With Prostate Cancer Risk: An Updated Meta-Analysis
OncoTargets and Therapy
Oncology
Pharmacology
FASL Rs763110 Polymorphism Contributes to Cancer Risk: An Updated Meta-Analysis Involving 43,295 Subjects
PLoS ONE
Multidisciplinary
Association Between IL-17A G197A Polymorphism and Gastric Cancer Risk: An Updated Meta-Analysis Based on 6,624 Cases and 7,631 Controls
OncoTargets and Therapy
Oncology
Pharmacology